On a per-share basis, the Brentford, Britain-based company said it had net income of 26 cents. Earnings, adjusted for non-recurring costs, were 59 cents per share. The results topped Wall Street ...

GSK has selected a site currently being constructed ... which is currently located to the west of the capital in Brentford and put up for sale last year. The company said in a statement that ...

GSK adds that the strength of these will overcome short-term vaccine challenges from external pressures in the US and China. The Brentford, U.K.-based company remains confident that Arexvy ...

(Alliance News) - GSK PLC on Friday reported the US Food & Drug Administration has accepted its Shingrix vaccine syringe for review. The Brentford, England-based pharmaceutical and biotechnology ...

(Alliance News) - GSK PLC on Monday said it has agreed to acquire Boston, Massachusetts-based IDRx Inc in a deal that will add to its "growing portfolio in gastrointestinal cancers". The Brentford ...

(Alliance News) - GSK PLC on Monday said the European Commission has expanded approval for its drug Jemperli, in combination with chemotherapy, to include all adult patients with primary advanced or ...